Cellebrite DI (CLBT) - Total Liabilities
Based on the latest financial reports, Cellebrite DI (CLBT) has total liabilities worth $454.53 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CLBT long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cellebrite DI - Total Liabilities Trend (2019–2025)
This chart illustrates how Cellebrite DI's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see CLBT total asset value.
Cellebrite DI Competitors by Total Liabilities
The table below lists competitors of Cellebrite DI ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Graphic Packaging Holding Company
NYSE:GPK
|
USA | $8.44 Billion |
|
HMS Networks AB (publ)
ST:HMS
|
Sweden | Skr3.04 Billion |
|
Chongqing Water Group Co Ltd
SHG:601158
|
China | CN¥18.67 Billion |
|
EXOSENS PROM
PA:EXENS
|
France | €444.20 Million |
|
Vicat S.A.
PA:VCT
|
France | €3.30 Billion |
|
Green Brick Partners Inc
NYSE:GRBK
|
USA | $601.78 Million |
|
Premium Brands Holdings Corporation
TO:PBH
|
Canada | CA$5.04 Billion |
|
Endeavour Silver Corp.
TO:EDR
|
Canada | CA$558.89 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Cellebrite DI's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CLBT equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.94 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cellebrite DI's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cellebrite DI (2019–2025)
The table below shows the annual total liabilities of Cellebrite DI from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $454.53 Million | +28.20% |
| 2024-12-31 | $354.55 Million | -28.90% |
| 2023-12-31 | $498.67 Million | +51.38% |
| 2022-12-31 | $329.43 Million | -20.26% |
| 2021-12-31 | $413.13 Million | +37.44% |
| 2020-12-31 | $300.58 Million | +35.76% |
| 2019-12-31 | $221.41 Million | -- |
About Cellebrite DI
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exp… Read more